Apollo Hospitals Share News - Latest Updates, Live News & More

Latest news about Apollo Hospitals

Apollo Hospitals: Block Trade of 151,706 Shares Valued at Rs. 104.52 Crores 4 days ago

A significant block trade of approximately 151,706 shares of Apollo Hospitals Enterprise Ltd. was executed on the National Stock Exchange (NSE). The transaction was priced at Rs. 6,889.50 per share, totaling Rs. 104.52 crores. This large-scale trade indicates substantial investor interest in the healthcare sector and Apollo Hospitals specifically. While the identities of the traders remain undisclosed, such transactions typically involve institutional investors or large shareholders.

Apollo Hospitals Sees Major Block Trade: 151,492 Shares Sold for Rs. 105.51 Crores 5 days ago

Apollo Hospitals Sees Major Block Trade: 105,375 Shares Change Hands at Rs. 6,950 Each 5 days ago

Apollo Hospitals Shines: HSBC Raises Target Price After Robust Q4 Performance Jun 03, 2025

Apollo Hospitals: Q4 Profit Soars 53%, Beats Estimates; Analysts Maintain Positive Outlook Jun 02, 2025

More news about Apollo Hospitals

01Jun 25

Apollo Hospitals Projects Healthco Cash EBITDA Breakeven by Q2/Q3 FY26

Apollo Hospitals anticipates its digital health initiative, Healthco, to achieve cash EBITDA breakeven by Q2/Q3 FY26, excluding ESOP costs. The company projects 25-30% YoY GMV growth for FY26 and expects the sales to GMV ratio to improve from 37% in FY25 to 40-45% in FY26. These projections indicate a strong focus on scaling Healthco's operations and improving its financial performance.

31May 25

Apollo Hospitals Unveils Ambitious Growth Strategy, Targets Rs 250 Billion Revenue by FY27

Apollo Hospitals has announced a comprehensive growth strategy focusing on international expansion beyond Bangladesh, aggressive pharmacy network growth with 600 new stores annually, and ambitious financial targets. The company aims to achieve Rs 250 billion in revenue by FY27, with a 24% CAGR from FY25 to FY27 and an EBITDA margin of 7-8%. This strategy emphasizes geographic diversification, expanding retail pharmacy presence, and maintaining profitability during rapid expansion.

31May 25

Apollo Hospitals Unveils Ambitious Expansion Plan with 1,937 New Beds

Apollo Hospitals has unveiled plans to add 1,937 beds, including 1,577 census beds, across seven projects. The expansion, estimated to cost Rs 3,165.00 crore, aims to significantly boost the company's healthcare capacity. A substantial portion of the investment, Rs 1,833.00 crore, is earmarked for fiscal year 2026.

30May 25

Apollo Hospitals: Rs 6,000 Crore Investment for 4,300 New Beds and Expansion in Bengaluru

Apollo Hospitals Enterprise Ltd plans to invest Rs 6,000 crore over 3-4 years to add 4,300 beds across India, with 2,000 beds expected within 12-15 months. In Bengaluru, the company will invest Rs 1,229 crore, including Rs 944 crore for land to develop a 500-bed hospital and Rs 285 crore to acquire an existing hospital. The company reported strong financial results with Q4 consolidated revenue up 13% to Rs 5,592 crore and net profit up 54% to Rs 390 crore. A final dividend of Rs 10 per share was announced.

30May 25

Apollo Hospitals: Q4 Profit Surges 59%, Beats Estimates

Apollo Hospitals announced strong Q4 results with consolidated net profit rising 59.30% to ₹411.50 crore. Revenue increased by 13.10% to ₹5,592.20 crore, while EBITDA grew 20.20% to ₹769.70 crore. The EBITDA margin improved to 13.76% from 12.96%. The company declared a dividend of ₹10.00 per share.

16May 25

Apollo Hospitals Enterprise Announces Internal Restructuring Plan

Apollo Hospitals Enterprise is implementing an internal restructuring plan, amalgamating Apollo Amrish Oncology Services Pvt Ltd (AAOSPL) with Apollo Hospitals International Ltd (AHIL), a wholly owned subsidiary. This move aims to streamline operations, potentially enhance oncology services, and optimize resource allocation within the group.

09May 25

Apollo Hospitals Sees Rs. 20.56 Crore Block Trade on NSE

A significant block trade of approximately 30,755 shares of Apollo Hospitals Enterprise Ltd. occurred on the National Stock Exchange (NSE). The shares were traded at Rs. 6,683.50 per share, totaling around Rs. 20.56 crore. This transaction highlights ongoing interest in the healthcare sector and Apollo Hospitals, one of India's largest integrated healthcare providers.

11Apr 25

Apollo Hospitals Sets Sights on Northern India Expansion Through Acquisitions

Apollo Hospitals Enterprise Ltd. plans to add 3,500 beds over the next 3-4 years, focusing on major cities like Kolkata, Hyderabad, and Mumbai. The company aims to strengthen its presence in northern India through strategic acquisitions. Apollo is also investing ₹240 crore in a new cancer center and focusing on high-growth specialties such as oncology, cardiac care, neurology, and preventive healthcare. This expansion strategy targets key urban centers and specialized care to capture a larger market share and enhance capabilities in high-demand medical areas.

24Mar 25

Apollo Healthco Expands Healthcare Footprint with 11.2% Stake in Keimed

Apollo Healthco, a subsidiary of Apollo Hospitals Enterprise Limited, has acquired an 11.2% stake in Keimed Private Limited for ₹6.25 billion ($75 million). This strategic move aims to strengthen Apollo Hospitals' market position in the Indian healthcare sector, potentially expanding its market reach, creating synergies, and diversifying its portfolio.

21Mar 25

Apollo Healthco Acquires 11.2% Stake in Keimed for ₹625.43 Crore

Apollo Hospitals Enterprise Limited's subsidiary, Apollo Healthco Limited, has completed the acquisition of an 11.2% stake in Keimed Private Limited for ₹625.43 crore. The transaction involved purchasing shares from a promoter and making a primary investment into Keimed. The deal was completed on March 20, 2025, following board approval in April 2024.

13Mar 25

Apollo Hospitals to Boost AI Investment, Aiming to Streamline Operations and Expand Capacity

Apollo Hospitals plans to increase investment in AI tools to automate routine tasks and reduce workload for medical staff, potentially saving 2-3 hours daily. The AI initiative focuses on diagnosis suggestions, medical transcription, and antibiotic prescription assistance. The company also aims to expand bed capacity by one-third over four years, partly funded by AI-driven cost savings.

10Mar 25

Apollo Hospitals Sees Significant Block Trade on NSE

A significant block trade of Apollo Hospitals Enterprise Ltd. shares occurred on the National Stock Exchange (NSE). The transaction involved 30,058 shares at Rs. 6,165.90 per share, totaling Rs. 18.53 crores. This large-scale trade has drawn market attention due to its potential implications for the company's stock and possible shifts in institutional holdings or investor perspectives.

05Mar 25

Apollo Hospitals Expands Cancer Care with Rs 250 Crore Investment in Proteus One System

Apollo Hospitals Enterprise Ltd plans to invest Rs 250 crore in a new Comprehensive Oncology Centre featuring India's first Proteus One Proton System. The project, to be completed by FY 2028, will add capacity for 350 patients annually. Apollo has partnered with Ion Beam Applications (IBA) for this expansion. Concurrently, a block trade of 30,325 shares at Rs 6,170.60 per share was executed on the NSE.

05Mar 25

Apollo Hospitals to Invest ₹250 Crore in Cutting-Edge Oncology Centre, Partnering with IBA for Proteus One System

Apollo Hospitals Enterprise Limited (AHEL) is investing ₹250 crore to establish a comprehensive oncology centre, featuring India's first Proteus One Proton System. The facility, set to open by FY 2028, will increase proton therapy treatment capacity by 350 patients annually, bringing the total capacity to 1,200 patients per year. This expansion addresses India's growing cancer care needs, as the country ranks third globally in new cancer incidences. The investment will be financed through internal accruals over three years.

04Mar 25

Apollo Hospitals to Invest ₹250 Crore in India's First Proteus One Proton Therapy System in Hyderabad

Apollo Hospitals Enterprise Limited plans to invest ₹250 crore over three years to establish a Comprehensive Oncology Centre in Hyderabad, featuring India's first Proteus One Proton System. The centre, set to be operational by FY2028, will have the capacity to treat an additional 350 patients annually. This investment aims to address India's growing cancer care needs, with the country expected to see 1.5 million new cancer cases this year.

25Feb 25

Apollo Hospitals Sees Rs. 22.01 Crore Block Trade on NSE

A significant block trade of 35,216 shares of Apollo Hospitals Enterprise Ltd. occurred on the National Stock Exchange at Rs. 6,250.50 per share, totaling Rs. 22.01 crores. The transaction, potentially indicating institutional activity or large stakeholder movements, has drawn market attention. Apollo Hospitals, a leading Indian healthcare provider, continues to be a key player in the sector.

21Feb 25

Apollo Hospitals Unveils ₹6,000 Crore Expansion Plan to Add 3,000 Beds Across India

Apollo Hospitals announces a ₹6,000 crore investment over three years to add 3,000 beds across major Indian cities including Mumbai, Gurgaon, Hyderabad, Chennai, and Bengaluru. The expansion plan includes growing their hospital network, pharmacy chain, clinic network, and digital health services. The company's pharmacy division has recently achieved mild profitability.